IndiaInfoline » Markets » IPCALAB

Ipca Laboratories Ltd - Share Price

IPCALAB

Open

975.00

Prev. Close

1,054.70

Turnover (lac.)

1

Day's High

976.00

Day's Low

970.00

52 Week's High

1,383.10

52 Week's Low

892.70

Book Value

209

Face Value

1

Mkt Cap (Cr.)

24,609

P/E

28.09

EPS

37.6

Divi. Yield

0.38

Ipca Laboratories LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Ipca Laboratories LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd884.00108.74194,118.20809.070.934,120.93113.47
Divis Laboratories Ltd3,850.0052.64110,935.34606.390.481,967.86372.89
Dr Reddys Laboratories Ltd4,400.0046.2874,862.73449.000.563,809.501,049.62
Cipla Ltd950.5026.0369,942.44782.370.583,858.82261.90
Piramal Enterprises Ltd2,530.00235.5160,310.3234.341.23515.35962.90

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Ipca Laboratories LtdSummary & Reports

Ipca Laboratories Limited (IPCA) was incorporated in 19th October of the year 1949 under the name of The Indian Pharmaceutical Combine Association Limited. Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 APIs covering various therapeutic segments. The products of the Company are now sold in over 120 countries across the globe. The Company has 17 manufacturing units in India ma... More

Registered Office

48 Kandivli Industrial Estate,Kandivli (West),Mumbai, Maharashtra,400067

Tell. : +91-22-66474444
Website : http://www.ipca.com
Email : ipca@ipca.co.in/investors@ipca.com

Registrar Office

C-101 247 Park, Vikhroli West, Mumbai-400083 INDIA

Tell. : +91-22-49186000
Website : www.linkintime.com
Email : rnt.helpdesk@linkintime.co.in/adaniwilmar.ipo@linkintime.co.in

Latest Release by ipca-labs-share-price

View

- <

Reco. Price

Jan 17,2022 01:05 PM

Target Price

Target Returns:

0.00%

Result Express

Ipca Laboratories Ltd's Q2FY19 standalone net profit rises 24.12% yoy to Rs119.74cr : In-line with Estimates

Jan 24, 2022 03:31 AM

The company’s standalone revenue stood at Rs997.82cr, up 15.4% yoy and 16.85% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Split

    Annc. Date

    13 Nov 2021

    Old FV

    New FV

    1

    Ex-Split Date

    10 Jan 2022

    Standalone and Consolidated Unaudited Financial Results along with limited review reports of the Com... More

    Jun 12, 2017

  • Purpose

    Board Meeting

    Exp. Date

    24 Dec 2021

    Annc. Date

    24 Dec 2021

    Board have decided to fix Tuesday, 11th January, 2022, as the Record Date for the Members entitlemen... More

  • Purpose

    EGM

    Exp. Date

    16 Dec 2021

    Annc. Date

    18 Nov 2021

    We are enclosing herewith copy of our Notice of the Extraordinary General Meeting of the Company sch... More

  • Purpose

    Board Meeting

    Exp. Date

    24 Nov 2021

    Annc. Date

    24 Nov 2021

    3The Board has approved the acquisition of 26.574% of the paid-up share capital of LykaLabs Limited ... More

OPEN A DEMAT ACCOUNT & Get
FREE Benefits worth 10,000